Rhythmm cuts prior authorization wait times from days to seconds. Our AI platform eliminates the number one cause of treatment delays, helping providers deliver care faster while reducing costs for everyone involved.
Rhythmm cuts prior authorization wait times from days to seconds. Our AI platform eliminates the number one cause of treatment delays, helping providers deliver care faster while reducing costs for everyone involved.
The current pre-authorization process in utilization review is manual, labor-intensive, and error-prone, resulting in substantial hardships for medical management companies, payers, employers, and patients. The inefficiencies lead to approval and denial delays, lack of real-time visibility, higher administrative costs, and an inability to prioritize critical patient needs or identify optimal treatment options. The absence of interoperability prevents steerage companies from proactively finding cost-effective services, while the fragmented and opaque process adversely impacts productivity, expenses, and patient outcomes, necessitating streamlining through automation and transparency for systemic improvement.
Since our soft launch in January 2024, Rhythmm has secured contracts worth $3.2M from third-party administrators and health plans, serving 27,000 covered lives. After full implementation in May 2024, we've achieved $165K in ARR with consistent 16.2% month-over-month growth. Our rapid adoption demonstrates a strong product-market fit in the healthcare payer space.
